Filter posts

Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story

This week, the Center for Medicine in the Public Interest issued a press release criticizing …

Tony Coelho: A Patient Advocate's Perspective on Paying for Value

Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House …

Answering the Call for Cures in Michigan

This week, the Kalamazoo Gazette published an op-ed on how we can accelerate the discovery, …

USDA Illuminates the Economic Benefits of Moving Toward a Biobased Economy

“A bioeconomy is one based on the use of research and innovation in the biological sciences to …

2014 BIO Investor Forum Fireside Chat with Nick Leschly and Chris Collins

Nick Leschly has served as bluebird bio’s president and chief executive officer since September 2010. …

Blurred Lines: Investors Explain Their Re-Thinking of Traditional Private-Only or Public-Only Invest...

The recent expansion and acceleration of the biotech stock market has seen a new willingness …